Fort Pitt Capital Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-23,347
Closed -$863K 115
2016
Q4
$863K Sell
23,347
-139
-0.6% -$4.97K 0.09% 72
2016
Q3
$814K Sell
23,486
-61
-0.3% -$2.14K 0.09% 66
2016
Q2
$766K Sell
23,547
-106
-0.4% -$3.25K 0.09% 68
2016
Q1
$680K Sell
23,653
-477
-2% -$12.7K 0.08% 70
2015
Q4
$806K Sell
24,130
-574
-2% -$17.8K 0.1% 65
2015
Q3
$703K Sell
24,704
-132
-0.5% -$4.6K 0.09% 67
2015
Q2
$1.01M Sell
24,836
-300
-1% -$13.5K 0.13% 65
2015
Q1
$1.24M Sell
25,136
-570
-2% -$26.4K 0.15% 64
2014
Q4
$1.17M Buy
+25,706
New +$1.01M 0.14% 63

Other funds holding AVNS

Fort Pitt Capital Group's AVNS Position: Q1 2017 in Review

Fort Pitt Capital Group sold out of Avanos Medical (AVNS) in Q1 2017, closing a stake of 23,347 shares — an estimated $863K sold.

Fort Pitt Capital Group first reported a position in AVNS in Q4 2014 and held it in 9 quarters. The position peaked at $1.24M in Q1 2015. 335 funds tracked by Wall St. Rank hold AVNS as of Q1 2017.

  • Fort Pitt Capital Group reported no remaining Avanos Medical position as of Q1 2017 after selling out during the quarter.
  • Fort Pitt Capital Group sold 23,347 Avanos Medical shares in Q1 2017, an estimated $863K.
  • Fort Pitt Capital Group first reported a position in Avanos Medical in Q4 2014 and held it in 9 quarters.
  • Fort Pitt Capital Group's Avanos Medical position peaked at $1.24M in Q1 2015.
  • 335 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2017.

Based on Fort Pitt Capital Group's 13F filing for Q1 2017, filed 11 May 2017.